Borgman Anne Elizabeth 4
4 · SUTRO BIOPHARMA, INC. · Filed Mar 4, 2024
Insider Transaction Report
Form 4
Borgman Anne Elizabeth
CHIEF MEDICAL OFFICER
Transactions
- Exercise/Conversion
Common Stock
2024-02-29+37,500→ 37,500 total - Tax Payment
Common Stock
2024-02-29$4.91/sh−13,126$64,449→ 24,374 total - Exercise/Conversion
Restricted Stock Unit (RSU)
2024-02-29−37,500→ 112,500 totalExp: 2027-02-28→ Common Stock (37,500 underlying)
Footnotes (3)
- [F1]Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock units; does not represent a sale by the reporting person.
- [F2]Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement.
- [F3]The RSU award vests as to 1/4th of the total award annually on the last calendar day of February, beginning on February 29, 2024, subject to continued service through each vesting date.